277 related articles for article (PubMed ID: 18778095)
1. High throughput lipidomic profiling of schizophrenia and bipolar disorder brain tissue reveals alterations of free fatty acids, phosphatidylcholines, and ceramides.
Schwarz E; Prabakaran S; Whitfield P; Major H; Leweke FM; Koethe D; McKenna P; Bahn S
J Proteome Res; 2008 Oct; 7(10):4266-77. PubMed ID: 18778095
[TBL] [Abstract][Full Text] [Related]
2. Glial fibrillary acidic protein mRNA levels in the cingulate cortex of individuals with depression, bipolar disorder and schizophrenia.
Webster MJ; O'Grady J; Kleinman JE; Weickert CS
Neuroscience; 2005; 133(2):453-61. PubMed ID: 15885920
[TBL] [Abstract][Full Text] [Related]
3. Decreased cortical gray and cerebral white matter in male patients with familial bipolar I disorder.
Davis KA; Kwon A; Cardenas VA; Deicken RF
J Affect Disord; 2004 Nov; 82(3):475-85. PubMed ID: 15555701
[TBL] [Abstract][Full Text] [Related]
4. Differences in neuroanatomical sites of apoD elevation discriminate between schizophrenia and bipolar disorder.
Thomas EA; Dean B; Scarr E; Copolov D; Sutcliffe JG
Mol Psychiatry; 2003 Feb; 8(2):167-75. PubMed ID: 12610649
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of the initiating step of the kynurenine pathway in postmortem anterior cingulate cortex from individuals with schizophrenia and bipolar disorder.
Miller CL; Llenos IC; Dulay JR; Weis S
Brain Res; 2006 Feb; 1073-1074():25-37. PubMed ID: 16448631
[TBL] [Abstract][Full Text] [Related]
6. Elevation of cell adhesion molecule immunoreactivity in the anterior cingulate cortex in bipolar disorder.
Thomas AJ; Davis S; Ferrier IN; Kalaria RN; O'Brien JT
Biol Psychiatry; 2004 Mar; 55(6):652-5. PubMed ID: 15013836
[TBL] [Abstract][Full Text] [Related]
7. Myelin staining of deep white matter in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and unipolar major depression.
Regenold WT; Phatak P; Marano CM; Gearhart L; Viens CH; Hisley KC
Psychiatry Res; 2007 Jun; 151(3):179-88. PubMed ID: 17433451
[TBL] [Abstract][Full Text] [Related]
8. Phospholipid membrane abnormalities and reduced niacin skin flush response in schizophrenia.
Buretić-Tomljanović A; Giacometti J; Nadalin S; Rubesa G; Vulin M; Tomljanović D
Psychiatr Danub; 2008 Sep; 20(3):372-83. PubMed ID: 18827766
[TBL] [Abstract][Full Text] [Related]
9. N-Ethylmaleimide sensitive factor in the cortex of subjects with schizophrenia and bipolar I disorder.
Gray L; Scarr E; Dean B
Neurosci Lett; 2006 Jan; 391(3):112-5. PubMed ID: 16165270
[TBL] [Abstract][Full Text] [Related]
10. 2-D DIGE analysis implicates cytoskeletal abnormalities in psychiatric disease.
English JA; Dicker P; Föcking M; Dunn MJ; Cotter DR
Proteomics; 2009 Jun; 9(12):3368-82. PubMed ID: 19562803
[TBL] [Abstract][Full Text] [Related]
11. Evidence for disease and antipsychotic medication effects in post-mortem brain from schizophrenia patients.
Chan MK; Tsang TM; Harris LW; Guest PC; Holmes E; Bahn S
Mol Psychiatry; 2011 Dec; 16(12):1189-202. PubMed ID: 20921955
[TBL] [Abstract][Full Text] [Related]
12. Medication effects on one-carbon metabolism in schizophrenia, mania, and major depression.
Morere DA; Alarcon RD; Monti JA; Walter-Ryan WG; Bancroft AJ; Smythies JR; Tolbert LC
J Clin Psychopharmacol; 1986 Jun; 6(3):155-61. PubMed ID: 2872235
[TBL] [Abstract][Full Text] [Related]
13. Changes in brain-derived neurotrophic factor following treatment with mifepristone in bipolar disorder and schizophrenia.
Mackin P; Gallagher P; Watson S; Young AH; Ferrier IN
Aust N Z J Psychiatry; 2007 Apr; 41(4):321-6. PubMed ID: 17464718
[TBL] [Abstract][Full Text] [Related]
14. Glial fibrillary acidic protein and glutamine synthetase in subregions of prefrontal cortex in schizophrenia and mood disorder.
Toro CT; Hallak JE; Dunham JS; Deakin JF
Neurosci Lett; 2006 Sep; 404(3):276-81. PubMed ID: 16842914
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical and immunoblot analysis of gamma-aminobutyric acid B receptor in the prefrontal cortex of subjects with schizophrenia and bipolar disorder.
Ishikawa M; Mizukami K; Iwakiri M; Asada T
Neurosci Lett; 2005 Aug; 383(3):272-7. PubMed ID: 15955420
[TBL] [Abstract][Full Text] [Related]
16. Ceramide profiles of the uninvolved skin in atopic dermatitis and psoriasis are comparable to those of healthy skin.
Farwanah H; Raith K; Neubert RH; Wohlrab J
Arch Dermatol Res; 2005 May; 296(11):514-21. PubMed ID: 15803327
[TBL] [Abstract][Full Text] [Related]
17. Independent protein-profiling studies show a decrease in apolipoprotein A1 levels in schizophrenia CSF, brain and peripheral tissues.
Huang JT; Wang L; Prabakaran S; Wengenroth M; Lockstone HE; Koethe D; Gerth CW; Gross S; Schreiber D; Lilley K; Wayland M; Oxley D; Leweke FM; Bahn S
Mol Psychiatry; 2008 Dec; 13(12):1118-28. PubMed ID: 17938634
[TBL] [Abstract][Full Text] [Related]
18. Density and distribution of white matter neurons in schizophrenia, bipolar disorder and major depressive disorder: no evidence for abnormalities of neuronal migration.
Beasley CL; Cotter DR; Everall IP
Mol Psychiatry; 2002; 7(6):564-70. PubMed ID: 12140779
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical and immunoblot analysis of Dopamine and cyclic AMP-regulated phosphoprotein, relative molecular mass 32,000 (DARPP-32) in the prefrontal cortex of subjects with schizophrenia and bipolar disorder.
Ishikawa M; Mizukami K; Iwakiri M; Asada T
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1177-81. PubMed ID: 17521792
[TBL] [Abstract][Full Text] [Related]
20. Regional brain gray matter abnormalities in patients with bipolar II disorder: a comparison study with bipolar I patients and healthy controls.
Ha TH; Ha K; Kim JH; Choi JE
Neurosci Lett; 2009 May; 456(1):44-8. PubMed ID: 19429131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
